A Phase II, multicenter, multinational, randomized, double-blinded, placebo-controlled dose-finding study to evaluate the efficacy and safety of carbabenzpyride in the treatment of uncomplicated influenza A. Prospective, multicenter, multinational, randomized, double-blinded, placebo-controlled dose-finding study in parallel groups (Phase II).
Latest Information Update: 11 Oct 2013
At a glance
- Drugs Carbabenzpyride (Primary)
- Indications Influenza A virus infections
- Focus Therapeutic Use
- 21 Jul 2011 This trial is prematurely ended in Germany and has completed in Austria.
- 20 Jul 2011 New trial record